Opthea Ltd
Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellectual property portfolio covering vascular endothelial growth factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well… Read more
Opthea Ltd (OPT) - Total Liabilities
Latest total liabilities as of December 2024: $314.48 Million USD
Based on the latest financial reports, Opthea Ltd (OPT) has total liabilities worth $314.48 Million USD as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Opthea Ltd - Total Liabilities Trend (1989–2024)
This chart illustrates how Opthea Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Opthea Ltd Competitors by Total Liabilities
The table below lists competitors of Opthea Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hebei Jianxin Chemical Co Ltd
SHE:300107
|
China | CN¥161.98 Million |
|
Suzhou New District Hi Tech Industrial Co Ltd
SHG:600736
|
China | CN¥59.74 Billion |
|
Shandong Intco Recycling Resources Co Ltd
SHG:688087
|
China | CN¥4.30 Billion |
|
mBank S.A.
PINK:MBAKF
|
USA | $258.84 Billion |
|
Trulieve Cannabis Corp
OTCQX:TCNNF
|
USA | $1.76 Billion |
|
Irish Residential Properties REIT Plc
PINK:RSHPF
|
USA | $589.47 Million |
|
Intellian Technologies Inc
KQ:189300
|
Korea | ₩237.02 Billion |
|
Wafer Works
TWO:6182
|
Taiwan | NT$10.61 Billion |
Liability Composition Analysis (1989–2024)
This chart breaks down Opthea Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.57 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Opthea Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Opthea Ltd (1989–2024)
The table below shows the annual total liabilities of Opthea Ltd from 1989 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | $264.60 Million | +68.56% |
| 2023-06-30 | $156.98 Million | +794.37% |
| 2022-06-30 | $17.55 Million | +321.89% |
| 2021-06-30 | $4.16 Million | -41.23% |
| 2020-06-30 | $7.08 Million | +8.23% |
| 2019-06-30 | $6.54 Million | -17.24% |
| 2018-06-30 | $7.90 Million | +285.02% |
| 2017-06-30 | $2.05 Million | -1.05% |
| 2016-06-30 | $2.07 Million | +15.03% |
| 2015-06-30 | $1.80 Million | -3.36% |
| 2014-06-30 | $1.87 Million | -0.40% |
| 2013-06-30 | $1.87 Million | -23.98% |
| 2012-06-30 | $2.46 Million | -13.90% |
| 2011-06-30 | $2.86 Million | +18.25% |
| 2010-06-30 | $2.42 Million | +19.69% |
| 2009-06-30 | $2.02 Million | -13.55% |
| 2008-06-30 | $2.34 Million | -53.20% |
| 2007-06-30 | $5.00 Million | +190.63% |
| 2006-06-30 | $1.72 Million | -59.90% |
| 2005-06-30 | $4.29 Million | +1273.22% |
| 2004-06-30 | $312.34K | -1.86% |
| 2003-06-30 | $318.25K | +52.37% |
| 2002-06-30 | $208.87K | +25.94% |
| 2001-06-30 | $165.85K | -23.95% |
| 2000-06-30 | $218.09K | +53.47% |
| 1999-06-30 | $142.11K | -12.25% |
| 1998-06-30 | $161.94K | -3.19% |
| 1997-06-30 | $167.27K | +75.54% |
| 1996-06-30 | $95.29K | +38.32% |
| 1995-06-30 | $68.89K | +114.27% |
| 1994-06-30 | $32.15K | +50.41% |
| 1993-06-30 | $21.38K | -44.97% |
| 1992-06-30 | $38.84K | +33.29% |
| 1991-06-30 | $29.14K | +14.81% |
| 1990-06-30 | $25.38K | -26.92% |
| 1989-06-30 | $34.73K | -- |